Hørsholm, Denmark

Lukasz Kielpinski

This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Genentech, Inc., Roche Innovation Center Copenhagen A/s. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lukasz Kielpinski. Retrieved from https://idiyas.com/inventor/lukasz-kielpinski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.9

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Lukasz Kielpinski

Introduction

Lukasz Kielpinski is a notable inventor based in Hørsholm, Denmark. He has made significant contributions to the field of biotechnology, particularly in the modulation of gene expression. His work focuses on developing innovative solutions for neurological disorders.

Latest Patents

Kielpinski holds a patent for "Oligonucleotides for modulating TMEM106B expression." This invention relates to oligonucleotides that are complementary to and modulate the expression of TMEM106B. The patent further encompasses conjugates of the oligonucleotide and pharmaceutical compositions, along with methods for treating neurological disorders using the oligonucleotide.

Career Highlights

Lukasz Kielpinski is currently associated with Genentech, Inc., a leading biotechnology company. His role involves research and development aimed at advancing therapeutic options for patients with neurological conditions. His expertise in oligonucleotide technology has positioned him as a key figure in his field.

Collaborations

Kielpinski has collaborated with notable colleagues such as Peter Hagedorn and Marianne Lerbech Jensen. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Lukasz Kielpinski's contributions to biotechnology, particularly through his patent on oligonucleotides, highlight his commitment to advancing medical science. His work continues to pave the way for new treatments for neurological disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…